Join in on May 21, 2019 at 1:00 pm EST to hear about A North American Multi-site Evaluation of the Cytocell® AML/MDS FISH probe kits, presented by Jaime Rohr and John Grignon from Wisconsin Diagnostic Laboratories, and Faidra Partheniou from Oxford Gene Technologies.
ADD TO CALENDAR
How to Join:
If you have participated in the AGT webinars in the past, be aware that there have been some changes to the process. There is no pre-registration form.
To join the webinar go to, https://join.freeconferencecall.com/agtinfonow.
You will be asked to enter your email address and name. Make sure you enter this correctly as it will be used for evaluation distribution. Upon completion of the webinar, you will be sent an evaluation for completion. You will be able to add in the names of others that viewed the webinar with you. However, only current AGT members will be provided CEU certificates. If you are not an AGT member, you are welcome to view the webinar but you will not receive a CEU certificate. The recorded webinars will be made available in the AGT website store at a later date. Non-members may purchase and complete the quiz at a cost of $20 for CEU credit.
Webinar Description:
A North American Multi-site Evaluation of the Cytocell® AML/MDS FISH probe kits
This webinar details the rigorous clinical and analytical studies carried out to demonstrate the safety and effectiveness of eight FISH probes for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) as part of an FDA submission. We present data that demonstrates the excellent analytical specificity, sensitivity, stability and reproducibility of the probes. We will also present data that shows the outstanding clinical performance and concordance with established methods. During the course of these studies, which spanned four sites, worldwide, over 2,500 replicates were run with no technical failures. The rigorous standards required for gaining FDA clearance are recognized globally and emphasize the exceptional quality of the Cytocell FISH probes from Oxford Gene Technology (OGT).